GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,636 | -4,440 | -7,120 | -5,150 | -5,990 |
| Depreciation Amortization | 443 | 830 | 1,550 | 1,220 | 1,380 |
| Accounts receivable | 567 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -501 | N/A | N/A | N/A | N/A |
| Other Working Capital | 233 | 360 | -250 | N/A | N/A |
| Other Operating Activity | 7 | 780 | 580 | -910 | 340 |
| Operating Cash Flow | $-3,887 | $-2,470 | $-5,240 | $-4,840 | $-4,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -160 | 1,710 | -100 | N/A | N/A |
| Other Investing Activity | -143 | 440 | -140 | -110 | -400 |
| Investing Cash Flow | $-303 | $2,150 | $-240 | $-110 | $-400 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -40 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 5,868 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -361 | -1,470 | 6,830 | 5,900 | 4,380 |
| Financing Cash Flow | $5,467 | $-1,470 | $6,830 | $5,900 | $4,380 |
| Exchange Rate Effect | -7 | 20 | -60 | -70 | -3 |
| Beginning Cash Position | 789 | 2,570 | 1,290 | 420 | 720 |
| End Cash Position | 2,059 | 780 | 2,570 | 1,290 | 420 |
| Net Cash Flow | $1,270 | $-1,780 | $1,280 | $860 | $-300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,887 | -2,470 | -5,240 | -4,840 | -4,270 |
| Capital Expenditure | -160 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,047 | -2,470 | -5,240 | -4,840 | -4,270 |